Nigeria has deposited its instrument of ratification of the African Medicines Agency (AMA) treaty, changing into the thirty fourth member state of the African Union to take action.
The ratification was introduced by the African Union Commissioner for Health, Humanitarian Affairs and Social Development, Ambassador A. Twum-Amoah, on the inaugural African Medicines Agency Week holding in Kigali, Rwanda, from October 25 to 30, 2026.
The assembly is being attended by medicines regulatory businesses throughout the continent, representatives of Regional Economic Communities, the World Health Organisation, the European Union and different improvement companions.
Director-General of the National Agency for Food and Drug Administration and Control, Prof. Mojisola Adeyeye, mentioned Nigeria’s ratification, as Africa’s most populous nation and one in all its largest pharmaceutical markets, will strengthen efforts to construct a extra coordinated and harmonised regulatory atmosphere for medicines and medical merchandise on the continent.
She mentioned the event reinforces Nigeria’s dedication to defending public well being, tackling substandard and falsified medical merchandise, selling pharmaceutical innovation and advancing native manufacturing as a part of well being safety and financial improvement.
According to her, the ratification supplies a chance to deepen collaboration between NAFDAC, AMA and different nationwide and regional regulatory establishments in pursuit of continental well being aims.
She added that Nigeria’s participation ought to translate into sensible motion by institutional collaboration, regulatory capability improvement, info sharing, scientific cooperation and efficient implementation of the treaty.
She famous that the success of AMA might be measured by its skill to make sure that Africans have entry to protected, efficient, quality-assured and reasonably priced medicines, pushed by the maturity of nationwide regulatory businesses.
“Nigeria’s ratification is not merely a diplomatic or legal achievement; it is a significant investment in Africa’s health security, pharmaceutical sovereignty and sustainable development,” she mentioned.
We’ve bought the sting. Get real-time stories, breaking scoops, and unique angles delivered straight to your cellphone. Don’t accept stale information. Join LEADERSHIP NEWS on WhatsApp for twenty-four/7 updates →
